Worldwide point-of-care testing: Compendiums of POCT for mobile, emergency, critical, and primary care and of infectious diseases tests

Point of Care

Volumn 5, Issue 2, 2006, Pages 84-92

  Tran, Nam K ^a   Kost, Gerald J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

And disposable reagent kit; And in vivo; And transportable; And whole blood analyzers; Chip; Critical care testing; Disposable reagent card; Ex vivo; Handheld; In vitro; Monitoring; Nucleic acid testing; Portable; Transcutaneous

Indexed keywords

EID: 33746612043     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/00134384-200606000-00010     Document Type: Article

References (48)

1. Kost GJ. New whole blood analyzers and their impact on cardiac and critical care. Crit Rev Clin Lab Sci. 1993;30:153-202.
2. Kost GJ, Hague C. In vitro, ex vivo, and in vivo biosensor systems. In: Kost GJ, ed. Handbook of Clinical Automation, Robotics, and Optimization. New York: John Wiley and Sons; Chapter 27, 1996:648-753.
3. Kost GJ. Point-of-Care Testing ⇒ The Hybrid Laboratory ⇒ Knowledge Optimization. In: Kost GJ, ed. Handbook of Clinical Automation, Robotics, and Optimization. New York: John Wiley and Sons; Chapter 28, 1996:757-838.
4. Cummings JP, Kost GJ, Matuszewski KA, Mulhern KM, Ratko TA. (contributing reviewers). POC Tests for Cardiac Injury Markers: Clinical Improvement and Effectiveness. Oak Brook, IL: University Health System Consortium; 2000. 38 pages.
5. Kost GJ. Point-of-care testing. In: Meyers RA, ed. Encyclopedia of Analytical Chemistry: Instrumentation and Applications. New York: John Wiley & Sons; Chapter 540, 2000:1603-1625.
6. Kost GJ. Principles and Practice of Point-of-Care Testing. Philadelphia: Lippincott, Williams, and Wilkins; 2002. 654 pages.
7. Tang Z, Louie RF, Kost GJ. Principles and performance of point-of-care testing instruments. In: Kost GJ, Ed. Principles and Practice of Point-of-Care Testing. Philadelphia: Lippincott, Williams, and Wilkins; chapter 6, 2002:67-92.
8. Cummings JP, Kost GJ, Matuszewski KA, Ratko TA. (contributing reviewers). UHC High-Impact Technology Brief: B-Type Natriuretic Peptide Blood Test. Oak Brook, IL: University Health System Consortium; 2003. 29 pages.
9. Nichols JH. Ed. Point-of-care Testing: Performance Improvement and Evidence-based Outcomes. New York: Marcel Dekker; 2003. 500 pages.
10. Price CP, St. John A, Hicks JM. Point-of-Care Testing. Washington, DC: AACC Press; 2004. 488 pages.
11. Price CP, St. John A. Point-of-care testing. In: Burtis CA, Ashwood ER, Bruns DE, Eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Washington, DC: AACC Press; volume 2, chapter 12, 2005:299-320.
12. Price CP, St. John, Hicks JM. Point-of-care testing. In: Cook KW, Lehman C, Schoeff, L, et al., Eds. Clinical Diagnostic Technology: The Total Testing Process - Pre-Analytical, Analytical, and Post-Analytical Phases. Washington, DC: AACC Press; chapter 17, 2005:403-406.
13. Kost GJ, Peungposop N, Kultrattanamaneeporn C, et al. Minimizing health problems to optimize demographic dividend: The role of point-of-care testing. In: Wongboonsin K, Guest P, Eds. The Demographic Dividend: Policy Options for Asia. Bangkok: College of Population Studies, Chulalongkorn University, Asian Development Research Forum, and the Thailand Research Fund, chapter 3, 2005:56-89.
14. Kost GJ, Tran NK. Point-of-care testing and cardiac biomarkers: The standard of care and vision for chest pain centers. Cardiol Clin. 2005;23:467-490.
15. Tran NK, Kost GJ. Point-of-care biosensors, miniaturization, and noninvasive monitoring. In: Cook KW, Lehman C, Schoeff L, et al., Eds., Clinical Diagnostic Technology: The Total Testing Process - Pre-Analytical, Analytical, and Post-Analytical Phases. Washington, DC: AACC Press; volume 3, in press. 2006.
16. Kost GJ. Overview of Point-of-Care Testing: Goals, Guidelines, and Principles. In: Charuruks N, Ed. Point-of-care Testing in Thailand. Bangkok: Chulalongkorn Press, 2006, Chapter 1, in press. [In the Thai language].
17. Bektas F, Eray O, Sari R, et al. Point of care blood ketone testing of diabetic patients in the emergency department. Endocr Res. 2004;30:395-402.
18. Martin DD, Shephard MD, Freeman H, et al. Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community. Med J Aus. 2005;182:524-527.
19. Engle WD, Jackson GL, Stehel EK, et al. Evaluation of a transcutaneous jaundice meter following hospital discharge in term and near-term neonates. J Perinatology. 2005;25:486-490.
20. Grossman HB, Messing E, Soloway M, et al. Detection of bladder cancer using a point-of-care proteomic assay. JAMA. 2005;293:810-816.
21. Rao LV, Jakubiak F, Sidwell JS, et al. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clin Chim Acta. 2005;356:178-183.
22. Sokoll LJ, Wians FH, Rema AT. Rapid intraoperative immunoassay of parathyroid hormone and other hormones: a new paradigm for point-of-care testing. Clin Chem. 2004;50:1126-1135.
23. Shoemaker WC, Belzberg H, Wo CC, et al. Multicenter study of noninvasive monitoring systems as alternatives to invasive monitoring of acutely ill emergency patients. Chest. 1998;114:1643-1652.
24. Willems WA, van den Berg LM, de Wit H, et al. Transcutaneous bilirubinometry with the Bilicheck in very premature newboards. J Matern Fetal Neonatal Med. 2004;16:209-214.
25. Rolinski B, Okorodudu AO, Kost GJ, et al. Evaluation of total bilirubin determination in neonatal whole-blood samples by multiwavelength photometry on the Roche OMNI S point-of-care analyzer. Point of Care: The Journal of Near-Patient Test and Technology. 2005;4:3-8.
26. Bewly B, Creed G, Kost GJ, et al. Multicenter study on analytic performance of a new point-of-care blood gas analyzer and its use in critical care testing. Point of Care: The Journal of Near-Patient Test and Technology. 2004;3:149-155.
27. Briggs C, Kunka S, Pennaneach C, et al. Performance evaluation of a new compact hematology analyzer, the Sysmex pocH-100i. Lab Hematol. 2003;9:225-233.
28. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Eng J Med. 2005;353:2158-2168.
29. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109:1497-1502.
30. Zimmerman CR, Mlynarek ME, Jordan JA, et al. An insulin infusion protocol in critically ill cardiothoracic surgery patients. Ann Pharmacother. 2004;38:1123-1128.
31. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27:461-467.
32. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Eng J Med. 2001;345:1359-1367.
33. VandenBerghe GH. Role of intravenous insulin therapy in critically ill patients. Endocr Pract. 2004;10(Suppl 2):17-20.
34. Krinsley JS. Association between hyperglycemia and increased hospital mortality in heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471-1478.
35. Personal communication, SICU, Duke University Medical Center, 8/9/95.
36. Personal communication, MICU/SICU, UC Davis Medical Center, 7/22/05.
37. Dr. Inuzucchi, email correspondence, Yale School of Medicine, 6/18/05.
38. A.P. Furnary, AACC Teleconference, OR/OHSU ICU, Portland, 5/11/05.
39. Personal communication, Department of Endocrinology, UC San Francisco Medical Center, 6/20/05.
40. University of Pittsburgh, Department of Critical Care, http://www.ccm. upmc.edu/pittway/insulin_iv_drip.htm, Accessed on 10/26/06.
41. Bruno A, William LS, Kent TA. How important is hyperglycemia during acute brain infarction? Neurologist. 2004;10:195-200.
42. Furnary AP, Wu YX, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: The Portland diabetic project. Endo Pract. 2004;10(Suppl 2):21-33.
43. Schelhase KG, Koepsell TD, Weiss NS. Glycemic control and the risk of multiple microvascular diabetic complications. Fam Med. 2005;37:125-130.
44. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;80:862-866.
45. VandenBerghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus gylcemic control. Crit Care Med. 2003;31:359-366.
46. Laird AM, Miller PR, Kilgo PD, et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004;56:1058-1062.
47. Nunnally ME. Con: Tight perioperative glycemic control: Poorly supported and risky. J Cardiothorac Vasc Anesth. 2005;19:689-690.
48. Schricker T, Carvalho G. Pro: Tight perioperative glycemic control. J Cardiothorac Vasc Anesth. 2005;19:684-688.